Dimension Inx
Biomaterials, reimagined.
Biomaterials, reimagined.
Dimension Inx is a biotechnology startup founded in 2017 with the slogan "Biomaterials, reimagined." The company takes a materials-centric approach to address patient needs by creating structures that replicate the body’s microenvironment to elicit a regenerative response. Their focus on biofunctionality and manufacturability sets them apart, and their highly adaptable platform is not limited to any single material. Dimension Inx collaborates with leading product and R&D organizations to co-create regenerative solutions. Their recent $12.00M Series A investment in February 2023 attracted a notable group of investors including KdT Ventures, Solas BioVentures, Alumni Ventures Blockchain Fund, Portal Innovation Ventures, Prime Movers Lab, and Revolution’s Rise of the Rest Seed Fund. This investment reflects the confidence in Dimension Inx's innovative approach to revolutionizing biomaterials and regenerative solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $12.00M | 6 |
|
01 Feb 2023 |
| Venture Round | $2.29M | - | 29 Nov 2021 | |
| Grant | $240.00K | 1 | U.S. Department of Defense | 03 May 2021 |
| Seed Round | $3.18M | 3 |
|
18 Nov 2020 |
No recent news or press coverage available for Dimension Inx.
We care about your data, and we'd love to use cookies make your experience better.
